Editorial: Cancer surveillance in achalasia: Better late than never

American Journal of Gastroenterology

Volumn 105, Issue 10, 2010, Pages 2150-2152

  Eckardt, Alexander J ^a   Eckardt, Volker F ^a  

^a DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPHIC GASTRITIS; BARRETT ESOPHAGUS; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER RISK; CANCER SURVIVAL; CLINICAL TRIAL; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOSCOPY; ESOPHAGUS ACHALASIA; ESOPHAGUS CANCER; ESOPHAGUS DILATATION; HUMAN; INTESTINE METAPLASIA; MYOTOMY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TUMOR BIOPSY; COMPLICATION; ESOPHAGEAL ACHALASIA; ESOPHAGEAL NEOPLASMS;

ESOPHAGEAL ACHALASIA; ESOPHAGEAL NEOPLASMS; HUMANS;

EID: 77957825088     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.257     Document Type: Review

References (18)

1. Dunaway PM, Wong RKH. Risk and surveillance intervals for squamous cellcarcinoma in achalasia. Gastrointest Endosc Clin N Am 2001; 11: 425-34.
2. American Society of Gastrointestinal Endoscopy. The role of endoscopy inthe surveillance of premalignant conditions of the upper gastrointestinaltract. Gastrointest Endosc 2006; 63: 570-80.
3. Leeuwenburgh I, Scholten P, Alderliesten J et al. Long-term esophagealcancer risk in patients with primary achalasia; a prospective study.Am J Gastroenterol 2010; 105:2144-9 (this issue).
4. Meijssen MAC, Tilanus HW, van Blankenstein M et al. Achalasia complicatedby oesophageal squamous cell carcinoma: a prospective study of195 patients. Gut 1992; 33: 155-8.
5. Abela JE, Going JJ, Mackenzie JF et al. Systematic four-quadrant biopsydetects Barrett's dysplasia in more patients than nonsystematic biopsy.Am J Gastroenerol 2008; 103: 850-5.
6. Eckardt VF, Hoischen T, Bernhard G. Life expectancy, complications, andcauses of death in patients with achalasia: results of a 33-year follow-upinvestigation. Eur J Gastroenterol Hepatol 2008; 20: 956-60.
7. Brossard E, Ollyo JB, Fontolliet CH et al. Achalasia and squamous cellcarcinoma of the esophagus: is an endoscopic surveillance justified? Gastroenterology 1992; 102 (Suppl): A4 (Abstract).
8. Th omas T, Abrams KR, De Caestecker JS et al. Metaanalysis: cancer risk inBarrett's oesophagus. Aliment Pharmacol Ther 2007; 26: 1465-77. (Pubitemid 350178802)
9. Barbiere JM, Lyratzopoulos G. Cost-effectiveness of endoscopic screeningfollowed by surveillance for Barrett's esophagus: a review. Gastroenterology 2009; 137: 1869-76.
10. Csendes A, Braghetto I, Burdiles P et al. Very late results of esophagomyotomyfor patients with achalasia: clinical, endoscopic, histologic, manometric,and acid reflux studies in 67 patients for a mean follow-up of 190months. Ann Surg 2006; 243: 196-203. (Pubitemid 43185438)
11. Mattioli S, Di Simone MP, Bassi F et al. Surgery for esophageal achalasia. Long term results with three different techniques. Hepatogastroenterology 1996; 43: 492-500. (Pubitemid 126443890)
12. Wychulis AR, Woolam GL, Andersen HA et al. Achalasia and carcinoma ofthe esophagus. JAMA 1971; 215: 4638-41.
13. Chuong JJ, DuBovik S, McCallum RW. Achalasia as a risk factor for esophagealcarcinoma. A reappraisal. Dig Dis Sci 1984; 29: 1105-8.
14. Aggestrup S, Holm JC, Sorensen HR et al. Does achalasia predispose tocancer of the esophagus? Chest 1992; 102: 1013-6.
15. Streitz JM, Ellis FH, Gibb SP et al. Achalasia and squamous cellcarcinoma of the esophagus: analysis of 241 patients. Ann Th orac Surg 1995; 59: 1604-9.
16. Sandler RS, Nyren O, Ekbom A et al. The risk of esophageal cancer inpatients with achalasia. A population based study. JAMA 1995; 274: 1359-62.
17. Brücher BL, Stein HJ, Bartels H et al. Achalasia and esophageal cancer:incidence, prevalence, and prognosis. World J Surg 2001; 25: 745-9. (Pubitemid 32531921)
18. Zaninotto G, Rizzetto C, Zambon P et al. Long-term outcome and riskof esophageal cancer aft er surgery for achalasia. Br J Surg 2008; 95: 1488-94.